Stefin A in plasma of patients with type 2 diabetes;Stefina A w osoczu krwi chorych na cukrzycȩ typu 2

Polskie Archiwum Medycyny Wewnetrznej

Volumn 111, Issue 3, 2004, Pages 319-325

  Piwowar, Agnieszka ^a   Fus, Izabela ^a   Kanapik Kordecka, Maria ^a   Warwas, Maria ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cathepsin B; Diabetes type 2; Stefin A

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE INHIBITOR; N ACETYL BETA GLUCOSAMINIDASE; STEFIN A;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

EID: 1942420179     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Turk V., Turk B., Turk D.: Lysosomal cysteine proteases: facts and opportunities. Europ. Mol. Biol. Org. J., 2001, 20, 4629.
2. Turk B., Turk V., Turk D.: Structural and functional aspects of papaian-like cysteine proteinases and their protein inhibitors. Biol. Chem., 1997, 378, 141.
3. Kos J., Schweiger A.: Cathepsins and cystatins in extracellular fluids - useful biological markers in cancer. Radiol. Oncol., 2002, 36, 176.
4. Knapik-Kordecka M.: Udział inhibitora alfa-1 proteinaz w powstawaniu uszkodzeń naczyniowych. Post. Med. Klin. Dośw., 1996, 5, 361.
5. Owen C.A., Campbell E.J.: The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol., 1999, 65, 137.
6. Warwas M., Piwowar A., Knapik-Kordecka M.: Aktywność katepsyny B i innych proteaz oraz glikozydaz w osoczu krwi chorych na cukrzycȩ insulinoniezależna̧. Diagn. Lab., 1999, 35, 413.
7. Piwowar A., Knapik-Kordecka M., Buczyńska H., Warwas M.: Plasma cystatin C concentration in non-insulin-dependent diabetes mellitus: relation with nephropathy. Arch. Immunol. Ther. Exp., 1999, 47, 327.
8. Knapik-Kordecka M., Piwowar A., Warwas M.: Stȩżenie cystatyny C, aktywność antypapainowa i antytrypsynowa osocza krwi u chorych na cukrzycȩ typu 2. Wiad. Lek., 2000, 53, 617.
9. Škrha J., Prázný M., Hilgertová J., Weiserová H.: Serum α-tocopherol and ascorbic acid concentrations in Type 1 and Type 2 diabetic patients with and withought angiopathy. Clin. Chim. Acta, 2003, 329, 103.
10. Barrett A.J.: Fluorymetric assay of cathepsin B and cathepsin H with methylocumarylamide substrates. Biochem. J., 1980, 187, 217.
11. Miralles J.M., Coralles J.J., Garcia-Diez L.C., Cabezas J.A., Reglero A.: N-acetyl-β-D-glucosaminidase and α-L-fucosidase activities in relation to glycosylated hemoglobin levels and retinopathy in diabetes. Clin. Chim. Acta, 1982, 121, 373.
12. Aleksandrowsky Y.A.: Molecular mechanisms of diabetic complications. Biochemistry (Mosc), 1998, 63, 1249.
13. Parks W.C.: Who are the proteolytic culpritis in vascular disease? J. Clin. Invest., 1999, 104, 1167.
14. Cimerman N., Meško-Brguljan P, Krašovec M., Šusković S., Kos J.: Circadian rythms of cysteine proteinases and cystatins, potential tumour markers, in normal sera. Radiol. Oncol., 2002, 36, 180.
15. Cimerman N., Meško-Brguljan P, Krašovec M., Šusković S., Kos J.: Serum concentration and circadian profiles of cathepsins B,H and L, and their inhibitors, stefins A and B, in asthma. Clin. Chim. Acta, 2001, 310, 113.
16. Piwowar A., Warwas M.: Cystatyna C jako wskażnik przesa̧czania kłȩbuszkowego nerek. Post. Hig. Med. Dośw., 2001, 55, 687.
17. Biondi-Zoccani G.G.L., Abbate A., Liuzzo G., Biasucci L.M.: Atherotrombosis, inflammation, and diabetes. J. Am. College Card., 2003, 41, 1071.
18. Jormsjo S., Wuttge D.M., Sirsjo A. i wsp.: Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Pathol., 2002, 161, 939.
19. Shi G.P, Sukhova G.K., Grubb A. i wsp.: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest., 1999, 104, 1191.
20. Chen J., Tung C.H., Mahmood U. i wsp.: In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002, 105, 2766.
21. Yologlu S., Sezgin A.T., Ozdemir R. i wsp.: Identifying risk factors in a mostly overweight patient population with coronary artery disease. Angiology, 2003, 54, 181.